| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |